133 followers
10-6-20: "37 eyes (37 patients) were randomized in the STOP-Uveitis study. 30 eyes were found to be eligible. The reduction in inflammatory scores were statistically significant. IV infusions of tocilizumab are effective in improving inflammation in eyes"